维普中文期刊产品整合服务
21篇 您的检索式:作者名="Lossnitzer"
    题名 作者 年代 出处 被引量
1Incidengce rates and predictors of major and minor depression in patients with heart failure显示文摘Lossnitzer N Herzog W Stork S 2013Int J Cardiol2013,167,2:1
2Three dimensional dual- phase whole-heart MR imaging:clinical implications for congenital heart disease显示文摘Hussain T Lossnitzer D Uribe S 2012Radiology2012,263,2:1
3Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy 显示文摘Lehrke S Lossnitzer D Schb M et at 2011Heart2011,97,9:1
4Impact of systolic and diastolic deformation indexes assessed by strain-encoded imaging to predict persistent severe myocardial dysfunction in patients after acute myocardial infarction at follow-up显示文摘Neizel M Korosoglou G Lossnitzer D 2010J Am Coll Cardiol2010,56,:1
5Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynam- ics, right ventricular function, and remodeling 显示文摘Shehata ML Lossnitzer D Skrok J 2011AJR2011,196,1:1
6Use of cardiovascular magnetic resonance for risk stratihcation in chronic heart fail- ure: prognostic value of late gadolinium enhaneement in pa- tients with non-ischaemic dilated cardiomyopathy显示文摘Lehrke S Lossnitzer D Schbb M 2011Heart2011,97,9:1
7Myocardial delayed en- hancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling显示文摘Shehata ML Lossnitzer D Skrok J 2011AJR2011,196,:1
8Epithelial markers for paraffin-embedded human tissues显示文摘Stefan Zotter Arndt Lossnitzer Klaus-Dietmar Kunze Martin Müller John Hilkens Jo Hilgers Philomena Hageman 1985Virchows Archiv A Pathological Anatomy and Histopathology1985,,2:1
9Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy显示文摘Lehrke S Lossnitzer D Schtib M 2011Heart2011,97,9:1
10Myocardialdelayed enhancement in pulmonary hypertension : pulmonaryhemodynamics,right ventricular function,and remodeling 显示文摘Shehata ML Lossnitzer D Skrok J 2011AJR Am J Roentgenol2011,196,1:1
11Instantaneous wave-free ratio(iFR) to determine hemodynamically significant coronary stenosis: A comprehensive review显示文摘Coronary angiography is considered to be the gold standard in the morphological evaluation of coronary artery stenosis. The morphological assessment of the severity of a coronary lesion is very subjective. Thus, the invasive fractional flow reserve(FFR) measurement represents the current standard for estimation of the hemodynamic significance of coronary artery stenosis. The FFR-guided revascularization strategy was initially classified as a Class-IA-recommendation in the 2014 European Society of Cardiology/European Association for Cardio-Thoracic Surgery guidelines on myocardial revascularization. Both the Deferral vs Performance of Percutaneous Coronary Intervention of Functionally Non-Significant Coronary Stenosis and Flow Reserve vs Angiography for Multivessel Evaluation studies showed no treatment advantage for hemodynamically insignificant stenoses. With the help of FFR(and targeted interventions), clinical results could be improved; however, the use in clinical practice is still limited due to the need of adenosine administration and a significant prolongation of the length of the procedure. Instantaneous wave-free ratio(iFR~) is a new innovative approach for the determination of the hemodynamic significance of coronary stenosis, which can be obtained at rest without the use of vasodilators. Regarding the periprocedural complications as well as prognosis, iFR~ showed non-inferiority to FFR in the SWEDEHEART and DEFINE-FLAIR trials. Furthermore, iFR~, enhanced by iFR~-pullback, provides the possibility to display the iFR~-change over the course of the vessel to create a hemodynamic map.Stefan Baumann Leonard Chandra Elizaveta Skarga Matthias Renker Martin Borggrefe Ibrahim Akin Dirk Lossnitzer 2018World Journal of Cardiology2018,10,12:1
12Tissue and tumor distributio n of human polymorphic epithelial mucin显示文摘 Hageman C Lossnitzer A 1998Cancer Rev1998,11,:1
13Incidence rates and predictors of major and minor depression in patients with heart failure显示文摘Lossnitzer N Herzog W Stark S 2013Int J Cardiol2013,167,2:1
14Three dimensional dual phase whole-heart MR imaging: clinical implications for congenital heart disease显示文摘Hussain T Lossnitzer D Uribe S el al 2012Radiology2012,263,2:1
15Incidence rates and predictors of major and minor depression in patients with heart failure显示文摘Lossnitzer N Herzog W Stork S e1 al 2015Int J Cardiol2015,167,2:1
16Tissue and tumor distribution of human polymorphic epithelial mucin显示文摘Zotter S Hageman PC Lossnitzer A 1988Cancer Rev1988,11,:1
17Myocardial delayed enhancement in pulmonary hypertension:pulmonary hemodynamics,right ventricular function,and remodeling显示文摘Shehata ML Lossnitzer D Skrok J 2011AJR Am J Roentgenol2011,196,:1
18Increased right ventricular septomarginal trabeculation mass is a novel marker for pulmonary hypertension:comparison with ventricular mass index and right ventricular mass显示文摘Vogel-Claussen J Shehata ML Lossnitzer D 2011Invest Radiol2011,46,:1
19Strain- encoded MRI for evaluation of left ventricular function and transmurality in acute myocardial infarction 显示文摘NEIZEL M LOSSNITZER D KOROSOGLOU G 2009Circ Cardio- vasc Imaging2009,2,:1
20Optimal duration for dual antiplatelet therapy with COMBO dual therapy stent显示文摘The COMBO stent(OrbusNeich Medical BV,the Netherlands)is a stainless-steel platform with the biodegradable abluminal coating containing antiproliferative sirolimus(5 mg/mm)and the luminal stent surface covered with anti-CD-34 antibody.The CD-34 antibodies essentially capture endothelial progenitor cells resulting in rapid re-endothelialization of the treated segment.Aydin Huseynov Michael Behnes Uzair Ansari Stefan Baumann Dirk Lossnitzer Ibrahim El-Battrawy Christian Fastner Martin Borggrefe Ibrahim Akin 2019Journal of Geriatric Cardiology2019,16,11:0
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费